Skrzypski, M.; Kołodziejski, P.A.; Pruszyńska-Oszmałek, E.; Wojciechowicz, T.; Janicka, P.; Krążek, M.; Małek, E.; Strowski, M.Z.; Nowak, K.W.
Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum. Int. J. Mol. Sci. 2022, 23, 9807.
https://doi.org/10.3390/ijms23179807
AMA Style
Skrzypski M, Kołodziejski PA, Pruszyńska-Oszmałek E, Wojciechowicz T, Janicka P, Krążek M, Małek E, Strowski MZ, Nowak KW.
Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum. International Journal of Molecular Sciences. 2022; 23(17):9807.
https://doi.org/10.3390/ijms23179807
Chicago/Turabian Style
Skrzypski, Marek, Paweł A. Kołodziejski, Ewa Pruszyńska-Oszmałek, Tatiana Wojciechowicz, Paulina Janicka, Małgorzata Krążek, Emilian Małek, Mathias Z. Strowski, and Krzysztof W. Nowak.
2022. "Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum" International Journal of Molecular Sciences 23, no. 17: 9807.
https://doi.org/10.3390/ijms23179807
APA Style
Skrzypski, M., Kołodziejski, P. A., Pruszyńska-Oszmałek, E., Wojciechowicz, T., Janicka, P., Krążek, M., Małek, E., Strowski, M. Z., & Nowak, K. W.
(2022). Daily Treatment of Mice with Type 2 Diabetes with Adropin for Four Weeks Improves Glucolipid Profile, Reduces Hepatic Lipid Content and Restores Elevated Hepatic Enzymes in Serum. International Journal of Molecular Sciences, 23(17), 9807.
https://doi.org/10.3390/ijms23179807
